Sign in

Back to the bill

89th General Assembly · Iowa Funnel one-pager · Tuesday, November 10, 2026

HSB 228: HSB 228

Became HF 729 · Its progress continues under the new number.

Sponsors

Not listed

Cost

See the fiscal note

2 million annually. This is due in part to the increase in drug expenses after cost-saving measures are eliminated, and also due to the increased reimbursement amount per unit for filling prescriptions. The total cost to the Commerce Revolving Fund is approxim…

House subcommittee · named February 18, 2021

  • Rep. Brian Best (R)
  • Rep. Eddie Andrews (R) · eddie.andrews@legis.iowa.gov
  • Rep. Bob Kressig (D) · bob.kressig@legis.iowa.gov

Lobbying · 7 for, 7 against

For: Bristol Myers Squibb Co.; CHAIN; Glaxo Smith Kline; Iowa Board of Pharmacy; Iowa Pharmacy Association; Johnson & Johnson Services, Inc.; Pharmaceutical Research and Manufacturers of America (PhRMA)

Against: Americas Health Insurance Plans (AHIP); CVS Health; Elevance Health, and its Affiliates dba Anthem, Inc.; Federation of Iowa Insurers; Iowa Total Care, A Subsidiary of Centene Corporation; Medica; United Healthcare Services, Inc.

In plain words

  1. February 18, 2021Filed in the House and sent to the Commerce committee
  2. February 18, 2021House subcommittee named: Best, Andrews and Kressig
  3. March 1, 2021Approved by the House committee
  4. March 3, 2021Approved by the House committee, and given a new number: HF 729

From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Tuesday, November 10, 2026. https://iowafunnel.com/bills/89/HSB228